9 Meters Biopharma Inc. (NMTRQ)

9 Meters Biopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018	2017 - 2014
Selling, General & Admin	11.01	9.66	10.52	10.57	10.66	Upgrade
Research & Development	31.01	22	10.93	13.72	7.56	Upgrade
Other Operating Expenses	0	5.1	32.27	0	0	Upgrade
Operating Expenses	42.02	36.76	53.72	24.28	18.22	Upgrade
Operating Income	-42.02	-36.76	-53.72	-24.28	-18.22	Upgrade
Interest Expense / Income	2.67	0.05	4.05	1.83	6.15	Upgrade
Other Expense / Income	-0.92	-0.03	3.73	0.94	-0.21	Upgrade
Pretax Income	-43.77	-36.78	-61.5	-27.05	-24.16	Upgrade
Net Income	-43.77	-36.78	-61.5	-27.05	-24.16	Upgrade
Shares Outstanding (Basic)	13	12	5	2	1	Upgrade
Shares Outstanding (Diluted)	13	12	5	2	1	Upgrade
Shares Change	6.58%	130.12%	216.97%	34.59%	108.29%	Upgrade
EPS (Basic)	-3.38	-3.03	-11.60	-16.20	-19.60	Upgrade
EPS (Diluted)	-3.38	-3.03	-11.60	-16.20	-19.60	Upgrade
Free Cash Flow	-37.25	-29.49	-19.41	-17.98	-15.18	Upgrade
Free Cash Flow Per Share	-2.88	-2.43	-3.67	-10.79	-12.26	Upgrade
EBITDA	-41.09	-36.72	-57.43	-25.2	-17.99	Upgrade
Depreciation & Amortization	0.01	0.01	0.02	0.02	0.02	Upgrade
EBIT	-41.1	-36.73	-57.45	-25.22	-18.01	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).